Acadia Pharmaceuticals | ACAD - Interest Income


Acadia Pharmaceuticals reported $7.24M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
ALKERMES USD 11.09M 949K Jun/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Corcept Therapeutics USD 5.02M 1.18M Jun/2025
Cytokinetics USD 13M 700K Jun/2025
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Incyte USD 25.14M 2.21M Jun/2025
J&J USD 2.12 0.17 Sep/2025
Moderna USD 81M 9M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Prothena USD 3.35M 443K Sep/2025
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Ultragenyx Pharmaceutical USD 5.79M 1.04M Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025